AtriCure (ATRC) News Today $31.50 -0.04 (-0.13%) (As of 12/17/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period AtriCure's (ATRC) "Overweight" Rating Reiterated at JPMorgan Chase & Co.JPMorgan Chase & Co. restated an "overweight" rating and set a $40.00 price target on shares of AtriCure in a research note on Tuesday.December 17 at 8:38 AM | marketbeat.comY Intercept Hong Kong Ltd Takes Position in AtriCure, Inc. (NASDAQ:ATRC)Y Intercept Hong Kong Ltd purchased a new stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 21,884 shares of the medical device company's stock, valued at approximDecember 15 at 4:22 AM | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Shares Sold by Orion Portfolio Solutions LLCOrion Portfolio Solutions LLC reduced its position in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 50.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 40,621 shares of the medical device company's stockDecember 15 at 4:12 AM | marketbeat.comBNP Paribas Financial Markets Decreases Stake in AtriCure, Inc. (NASDAQ:ATRC)BNP Paribas Financial Markets decreased its position in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 86.3% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 12,534 shares of the medical device company's stock after selling 79,020 shares duringDecember 15 at 3:22 AM | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Given Average Rating of "Buy" by AnalystsShares of AtriCure, Inc. (NASDAQ:ATRC - Get Free Report) have been assigned a consensus rating of "Buy" from the eight brokerages that are currently covering the firm, Marketbeat reports. Eight analysts have rated the stock with a buy recommendation. The average 1 year price target among analystsDecember 15 at 2:16 AM | marketbeat.comAtriCure price target raised to $61 from $53 at CanaccordDecember 11, 2024 | markets.businessinsider.comCanaccord Genuity Group Raises AtriCure (NASDAQ:ATRC) Price Target to $61.00December 11, 2024 | americanbankingnews.comFmr LLC Decreases Stock Position in AtriCure, Inc. (NASDAQ:ATRC)Fmr LLC decreased its stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 53.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 973,456 shares of the medical device company's stock after sellinDecember 10, 2024 | marketbeat.comTwo Sigma Advisers LP Has $18.62 Million Stock Holdings in AtriCure, Inc. (NASDAQ:ATRC)Two Sigma Advisers LP raised its holdings in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 14.6% in the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 664,100 shares of the medical device company's stock after acquiring an additional 84,700 shares durinDecember 9, 2024 | marketbeat.comAtom Investors LP Makes New $1.74 Million Investment in AtriCure, Inc. (NASDAQ:ATRC)Atom Investors LP purchased a new stake in AtriCure, Inc. (NASDAQ:ATRC - Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 62,095 shares of the medical device company's stock, valued at approximately $1,741,000December 3, 2024 | marketbeat.comPDT Partners LLC Buys New Shares in AtriCure, Inc. (NASDAQ:ATRC)PDT Partners LLC purchased a new position in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm purchased 23,701 shares of the medical device company's stock, vDecember 3, 2024 | marketbeat.comBridgewater Associates LP Sells 20,632 Shares of AtriCure, Inc. (NASDAQ:ATRC)Bridgewater Associates LP decreased its stake in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 51.2% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 19,685 shares of the medical device company's stock after selling 20,6December 3, 2024 | marketbeat.comIntech Investment Management LLC Takes $427,000 Position in AtriCure, Inc. (NASDAQ:ATRC)Intech Investment Management LLC acquired a new position in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 15,214 shares of the medical device compDecember 3, 2024 | marketbeat.comHealthcare of Ontario Pension Plan Trust Fund Invests $1.99 Million in AtriCure, Inc. (NASDAQ:ATRC)Healthcare of Ontario Pension Plan Trust Fund bought a new stake in AtriCure, Inc. (NASDAQ:ATRC - Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 71,000 shares of the medical device company's stocDecember 2, 2024 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Shares Sold by Wasatch Advisors LPWasatch Advisors LP lowered its stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 2.6% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 769,252 shares of the medical device company's stock aDecember 1, 2024 | marketbeat.comShort Interest in AtriCure, Inc. (NASDAQ:ATRC) Declines By 25.8%AtriCure, Inc. (NASDAQ:ATRC - Get Free Report) saw a significant decline in short interest in November. As of November 15th, there was short interest totalling 1,670,000 shares, a decline of 25.8% from the October 31st total of 2,250,000 shares. Based on an average daily trading volume, of 567,600 shares, the short-interest ratio is presently 2.9 days.November 29, 2024 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Shares Could Be 26% Below Their Intrinsic Value EstimateNovember 28, 2024 | uk.finance.yahoo.comBNP PARIBAS ASSET MANAGEMENT Holding S.A. Raises Stake in AtriCure, Inc. (NASDAQ:ATRC)BNP PARIBAS ASSET MANAGEMENT Holding S.A. boosted its holdings in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 31.5% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 500,649 shares of the medical device company's stockNovember 24, 2024 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Grows Position in AtriCure, Inc. (NASDAQ:ATRC)Connor Clark & Lunn Investment Management Ltd. raised its position in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 39.4% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 185,819 shares ofNovember 24, 2024 | marketbeat.comB. Metzler seel. Sohn & Co. Holding AG Makes New Investment in AtriCure, Inc. (NASDAQ:ATRC)B. Metzler seel. Sohn & Co. Holding AG bought a new position in AtriCure, Inc. (NASDAQ:ATRC - Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 31,366 shares of the medical device company's stock, valuedNovember 24, 2024 | marketbeat.comAtriCure to Participate in the Piper Sandler 36th Annual Healthcare ConferenceNovember 21, 2024 | finance.yahoo.comAtriCure, Inc. (NASDAQ:ATRC) Given Consensus Recommendation of "Buy" by BrokeragesAtriCure, Inc. (NASDAQ:ATRC - Get Free Report) has received an average recommendation of "Buy" from the nine ratings firms that are currently covering the stock, MarketBeat.com reports. Nine analysts have rated the stock with a buy rating. The average twelve-month target price among brokers that hNovember 20, 2024 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Shares Sold by Assetmark Inc.Assetmark Inc. reduced its holdings in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 95.2% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,406 shares of the medical device company's stock after seNovember 19, 2024 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Sees Significant Decrease in Short InterestAtriCure, Inc. (NASDAQ:ATRC - Get Free Report) was the recipient of a significant decline in short interest in October. As of October 31st, there was short interest totalling 2,250,000 shares, a decline of 31.6% from the October 15th total of 3,290,000 shares. Based on an average trading volume of 586,600 shares, the days-to-cover ratio is currently 3.8 days.November 14, 2024 | marketbeat.comAtriCure to Participate in the Stifel 2024 Healthcare ConferenceNovember 8, 2024 | finance.yahoo.comEmerald Advisers LLC Acquires 38,421 Shares of AtriCure, Inc. (NASDAQ:ATRC)Emerald Advisers LLC increased its holdings in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 10.9% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 389,836 shares of the medical device company's stock afteNovember 3, 2024 | marketbeat.comUS$42.67 - That's What Analysts Think AtriCure, Inc. (NASDAQ:ATRC) Is Worth After These ResultsNovember 3, 2024 | finance.yahoo.comAtriCure Third Quarter 2024 Earnings: Beats ExpectationsNovember 1, 2024 | finance.yahoo.comAtriCure Inc (ATRC) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Market ChallengesOctober 31, 2024 | finance.yahoo.comOppenheimer Sticks to Its Buy Rating for Atricure (ATRC)October 31, 2024 | markets.businessinsider.comAtriCure (NASDAQ:ATRC) Stock Price Expected to Rise, Canaccord Genuity Group Analyst SaysCanaccord Genuity Group increased their target price on shares of AtriCure from $49.00 to $53.00 and gave the stock a "buy" rating in a research note on Wednesday.October 30, 2024 | marketbeat.comAtriCure price target raised to $36 from $32 at OppenheimerOctober 30, 2024 | msn.comAtriCure (NASDAQ:ATRC) Posts Quarterly Earnings ResultsAtriCure (NASDAQ:ATRC - Get Free Report) issued its earnings results on Tuesday. The medical device company reported ($0.17) EPS for the quarter, beating the consensus estimate of ($0.19) by $0.02. The company had revenue of $115.91 million during the quarter, compared to analysts' expectations of $112.23 million. AtriCure had a negative net margin of 9.33% and a negative return on equity of 8.39%. The business's revenue for the quarter was up 17.9% compared to the same quarter last year. During the same period in the previous year, the company earned ($0.20) EPS.October 30, 2024 | marketbeat.comAtriCure (NASDAQ:ATRC) Shares Gap Up After Earnings BeatAtriCure (NASDAQ:ATRC) Shares Gap Up Following Better-Than-Expected EarningsOctober 30, 2024 | marketbeat.comAtriCure, Inc. (NASDAQ:ATRC) Short Interest UpdateAtriCure, Inc. (NASDAQ:ATRC - Get Free Report) was the recipient of a significant decline in short interest in the month of October. As of October 15th, there was short interest totalling 3,290,000 shares, a decline of 8.4% from the September 30th total of 3,590,000 shares. Based on an average daily volume of 622,900 shares, the days-to-cover ratio is currently 5.3 days.October 30, 2024 | marketbeat.comAtriCure (NASDAQ:ATRC) Stock Quotes, Forecast and News SummaryOctober 30, 2024 | benzinga.comAtriCure’s Strong Growth and Strategic Initiatives Earn Buy Rating from Analyst Daniel StauderOctober 30, 2024 | markets.businessinsider.comAtriCure, Inc. (ATRC) Q3 2024 Earnings Call TranscriptOctober 30, 2024 | seekingalpha.comAtriCure (NASDAQ:ATRC) Releases FY 2024 Earnings GuidanceAtriCure (NASDAQ:ATRC) updated its FY 2024 earnings guidance. The company provided EPS guidance of -0.800--0.740 for the period, compared to the consensus estimate of -0.790. The company also issued revenue guidance of $459.0 millionillion-$462.0 millionillion, compared to the consensus estimate of $458.1 millionillion.October 29, 2024 | marketbeat.comAtriCure Reports Third Quarter 2024 Financial ResultsOctober 29, 2024 | businesswire.comAssenagon Asset Management S.A. Has $6.43 Million Position in AtriCure, Inc. (NASDAQ:ATRC)Assenagon Asset Management S.A. boosted its position in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 151.6% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 229,130 shares of the medical device company's stock afteOctober 29, 2024 | marketbeat.comAtriCure to Participate in the UBS Global Healthcare ConferenceOctober 28, 2024 | finance.yahoo.comAtriCure, Inc. (NASDAQ:ATRC) Receives Average Rating of "Buy" from BrokeragesShares of AtriCure, Inc. (NASDAQ:ATRC - Get Free Report) have been given a consensus rating of "Buy" by the nine brokerages that are covering the firm, Marketbeat.com reports. Nine equities research analysts have rated the stock with a buy rating. The average twelve-month price objective among broOctober 26, 2024 | marketbeat.comAtriCure (ATRC) Scheduled to Post Earnings on TuesdayAtriCure (NASDAQ:ATRC) will be releasing earnings after the market closes on Tuesday, October 29, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=633724)October 22, 2024 | marketbeat.comSG Americas Securities LLC Makes New $488,000 Investment in AtriCure, Inc. (NASDAQ:ATRC)SG Americas Securities LLC bought a new stake in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) during the 3rd quarter, according to its most recent filing with the SEC. The fund bought 17,393 shares of the medical device company's stock, valued at approximately $488,000. Several other institOctober 17, 2024 | marketbeat.comAtriCure Announces Launch of cryoSPHERE MAX™ Probe for Post-Operative Pain ManagementOctober 15, 2024 | finance.yahoo.comShareholders in AtriCure (NASDAQ:ATRC) are in the red if they invested three years agoOctober 13, 2024 | uk.finance.yahoo.comAtriCure to Announce Third Quarter 2024 Financial ResultsOctober 8, 2024 | finance.yahoo.comAtriCure, Inc. (NASDAQ:ATRC) Shares Sold by Dimensional Fund Advisors LPDimensional Fund Advisors LP cut its stake in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 28.0% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 705,699 shares of the medical device company's stock after selling 274,740 shares during the period. DiOctober 6, 2024 | marketbeat.comMillennium Management LLC Has $21.69 Million Stake in AtriCure, Inc. (NASDAQ:ATRC)Millennium Management LLC increased its position in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 132.5% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 952,765 shares of the medical dOctober 5, 2024 | marketbeat.com Get AtriCure News Delivered to You Automatically Sign up to receive the latest news and ratings for ATRC and its competitors with MarketBeat's FREE daily newsletter. Email Address DeFi Coin on Verge of Breakout! (Ad)The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Claim your FREE book now before it's too late! ATRC Media Mentions By Week ATRC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ATRC News Sentiment▼0.960.79▲Average Medical News Sentiment ATRC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ATRC Articles This Week▼84▲ATRC Articles Average Week Get AtriCure News Delivered to You Automatically Sign up to receive the latest news and ratings for ATRC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ITGR News Today IART News Today ATEC News Today OFIX News Today SRDX News Today ANGO News Today ARAY News Today RMTI News Today RSLS News Today ABT News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ATRC) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AtriCure, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AtriCure With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
